Blood Clot Retrieval Devices Market Size, Share, Report To 2033

(MENAFN- Straits Research) Introduction

Blood clot retrieval devices are advanced medical instruments designed to remove blood clots from blood vessels during procedures aimed at treating conditions like deep vein thrombosis (DVT), pulmonary embolism, or stroke. These devices work by physically extracting or breaking down the clot obstructing the blood vessel, helping to restore normal circulation and preventing further damage to organs and tissues.

Market Dynamics Rising cases of stroke worldwide drive the global market

The rising prevalence of strokes, particularly ischemic strokes, is a major factor driving the global blood clot retrieval devices market . Contributing factors such as sedentary lifestyles, an aging population, and the growing incidence of hypertension and diabetes are significantly increasing the global stroke burden.

• For example, the CDC reports that every 40 seconds, an individual in the U.S. suffers a stroke, amounting to over 795,000 cases annually. Among these, 610,000 are first-time strokes, while 185,000 occur in individuals with a prior history, highlighting the urgent need for rapid and effective stroke treatment solutions.

As stroke rates continue to escalate globally, the demand for advanced blood clot retrieval devices is expected to surge, fostering market growth and accelerating innovation in minimally invasive thrombectomy procedures.

Adoption of robotic-assisted thrombectomy creates tremendous opportunities

The integration of robotic-assisted technology in blood clot retrieval is transforming stroke treatment by enhancing precision, reducing procedure time, and improving patient outcomes. By enabling remote-controlled thrombectomy, robotics minimizes human error and expands access to specialized stroke care, particularly in regions with limited neurovascular expertise.

• For instance, in May 2024, Rapid Medical successfully performed the first robotic thrombectomy using the Robotic TIGERTRIEVER. This device, which autonomously adapts to a patient's anatomy, was used to treat two patients, marking a significant breakthrough in endovascular stroke treatment.

As robotic-assisted thrombectomy continues to gain traction, it is expected to enhance procedural accuracy, expand stroke care accessibility, and drive further innovation and investment in the global market.

Regional Analysis

North America holds the largest share in the global blood clot retrieval devices market, driven by the high prevalence of ischemic strokes, rapid adoption of innovative thrombectomy technologies, and advanced healthcare infrastructure. The region benefits from favorable reimbursement policies, strong government support for stroke treatment, and a well-established network of stroke centers. Moreover, leading market players such as Medtronic, Stryker, and Penumbra continue to invest in research and development, introducing next-generation thrombectomy devices.

Key Highlights

• The global blood clot retrieval devices market size was valued at USD 1.97 billion in 2024 and is projected to grow from USD 2.32 billion in 2025 to reach USD 5.10 billion by 2033, exhibiting a CAGR of 10.43% during the forecast period (2025-2033).
• Based on type, the global blood clot retrieval devices market is segmented into guidewires, aspiration devices, stent retrievers, and others. The stent retrievers blood clot retrieval segment is the largest revenue contributor.
• Based on application, the global market is segmented into coronary arteries, peripheral arteries, cerebral arteries, and others. The cerebral arteries segment is the largest revenue contributor to the market.
• Based on end-users, the global blood clot retrieval devices market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment is the largest revenue contributor to the market.
• North America is the highest shareholder in the global market.

Competitive Players

Johnson and Johnson

Stryker Corporation

Boston Scientific Corporation

Abbott Laboratories

AngioDynamics Inc.

Terumo Corporation

Koninklijke Philips N.V.

BIOTRONIK

Argon Medical Devices

Straub Medical

B SE

Perfuze Ltd.

Recent Developments

• In September 2024, Argon Medical Devices launched the CLEANER Vac Thrombectomy System for peripheral venous clot removal. This innovation enhances efficacy in thrombus clearance, supporting the growing adoption of minimally invasive thrombectomy solutions .

Segmentation

By Type

Guidewires

Aspiration Devices

Stent Retrievers

Others

By Application

Coronary Arteries

Peripheral Arteries

Cerebral Arteries

By End User

Hospitals and Clinics

Ambulatory Surgery Centres

Others

By Regions

North America

Europe

Asia-Pacific

Central & South America

The Middle East and Africa

MENAFN24032025004597010339ID1109349664